Drug Safety Newsletter – Edition 119 – 09 June 2025
09/06/2025
Medicines for human use
Safety update
The latest edition of the HPRA newsletter includes important updates to support the safe and appropriate use of the following medicines:
- Finasteride and dutasteride: Outcome of EU review regarding risk of suicidal ideation
- Bilastine oral formulations: New warning on the risk of QT prolongation/Torsade de points
- Azathioprine: Update to warning on hepatotoxicity and monitoring
- Mesalazine: New warning regarding the risk of idiopathic intracranial hypertension